Inhibition of pyruvic acid oxidation by 2,5-substituted 1,3,4-oxadiazoles.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003500:Cyclization; D008297:Male; D008722:Methods; D010069:Oxadiazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D010084:Oxidation-Reduction; D011773:Pyruvates / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051381:Rats; D013329:Structure-Activity Relationship; D013882:Thiosemicarbazones
D010069:Oxadiazoles; D011773:Pyruvates; D013882:Thiosemicarbazones